Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients

Por Bachelot, T, Ray-Coquard, I, Menetrier-Caux, C, Rastkha, M, Duc, A, Blay, J-Y
Publicado em 2003

Open-label feasibility study of pazopanib, carboplatin, and paclitaxel in women with newly diagnosed, untreated, gynaecologic tumours: a phase I/II trial of the AGO study group

Por du Bois, A, Vergote, I, Wimberger, P, Ray-Coquard, I, Harter, P, Curtis, L B, Mitrica, I
Publicado em 2012

Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas

Por Ray-Coquard, I, Ghesquière, H, Bachelot, T, Borg, C, Biron, P, Sebban, C, LeCesne, A, Chauvin, F, Blay, J-Y
Publicado em 2001

Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy

Por Ray-Coquard, I, Borg, C, Bachelot, Th, Sebban, C, Philip, I, Clapisson, G, Le Cesne, A, Biron, P, Chauvin, F, Blay, J Y
Publicado em 2003

Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO

Por Ray-Coquard, I, Favier, L, Weber, B, Roemer-Becuwe, C, Bougnoux, P, Fabbro, M, Floquet, A, Joly, F, Plantade, A, Paraiso, D, Pujade-Lauraine, E
Publicado em 2013

A controlled ‘before-after’ study: impact of a clinical guidelines programme and regional cancer network organization on medical practice

Por Ray-Coquard, I, Philip, T, de Laroche, G, Froger, X, Suchaud, J-P, Voloch, A, Mathieu-Daudé, H, Fervers, B, Farsi, F, Browman, G P, Chauvin, F
Publicado em 2002

A phase I/II study of 4 monthly courses of high-dose cyclophosphamide and thiotepa for metastatic breast cancer patients

Por Bachelot, T, Gomez, F, Biron, P, Ray-Coquard, I, Soler-Michel, P, Philip, I, Guastalla, J P, Rebattu, P, Dumortier, A, Droz, J P, Blay, J Y
Publicado em 2002

A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region

Por Cassier, P A, Ducimetière, F, Lurkin, A, Ranchère-Vince, D, Scoazec, J-Y, Bringuier, P-P, Decouvelaere, A-V, Méeus, P, Cellier, D, Blay, J-Y, Ray-Coquard, I
Publicado em 2010

Intensified dose of cyclophosphamide with G-CSF support versus standard dose combined with platinum in first-line treatment of advanced ovarian cancer a randomised study from the G...

Por Ray-Coquard, I, Paraiso, D, Guastalla, J-P, Leduc, B, Guichard, F, Martin, C, Chauvenet, L, Haddad-Guichard, Z, Lepillé, D, Orfeuvre, H, Gautier, H, Castera, D, Pujade-Lauraine, É
Publicado em 2007

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted olid tumours

Por Adenis, A, Ray-Coquard, I, Italiano, A, Chauzit, E, Bui-Nguyen, B, Blay, J-Y, Tresch-Bruneel, E, Fournier, C, Clisant, S, Amela, E Y, Cassier, P A, Molimard, M, Penel, N
Publicado em 2013

Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay

Por Verronèse, E., Delgado, A., Valladeau-Guilemond, J., Garin, G., Guillemaut, S., Tredan, O., Ray-Coquard, I., Bachelot, T., N'Kodia, A., Bardin-Dit-Courageot, C., Rigal, C., Pérol, D., Caux, C., Ménétrier-Caux, C.
Publicado no Oncoimmunology (2015)

Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis

Por Dufresne, A, Bertucci, F, Penel, N, Le Cesne, A, Bui, B, Tubiana-Hulin, M, Ray-Coquard, I, Cupissol, D, Chevreau, C, Perol, D, Goncalves, A, Jimenez, M, Bringuier, P P, Blay, J Y
Publicado em 2010

Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes

Por Pecorelli, S., Ray-Coquard, I., Tredan, O., Colombo, N., Parma, G., Tisi, G., Katsaròs, D., Lhommé, C., Lissoni, A. A., Vermorken, J. B., du Bois, A., Poveda, A., Frigerio, L., Barbieri, P., Carminati, P., Brienza, S., Guastalla, J. P.
Publicado em 2010

A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group

Por Cassier, P A, Lefranc, A, Y Amela, E, Chevreau, C, Bui, B N, Lecesne, A, Ray-Coquard, I, Chabaud, S, Penel, N, Berge, Y, Dômont, J, Italiano, A, Duffaud, F, Cadore, A-C, Polivka, V, Blay, J-Y
Publicado em 2013

Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter study

Por Zhang, A Y, Judson, I, Benson, C, Wunder, J S, Ray-Coquard, I, Grimer, R J, Quek, R, Wong, E, Miah, A B, Ferguson, P C, Dufresne, A, Teh, J Y H, Stockler, M, Tattersall, M H N
Publicado no Br J Cancer (2017)

Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions

Por Ray-Coquard, I., Montesco, M. C., Coindre, J. M., Dei Tos, A. P., Lurkin, A., Ranchère-Vince, D., Vecchiato, A., Decouvelaere, A. V., Mathoulin-Pélissier, S., Albert, S., Cousin, P., Cellier, D., Toffolatti, L., Rossi, C. R., Blay, J. Y.
Publicado em 2012

Advanced chondrosarcomas: role of chemotherapy and survival

Por Italiano, A., Mir, O., Cioffi, A., Palmerini, E., Piperno-Neumann, S., Perrin, C., Chaigneau, L., Penel, N., Duffaud, F., Kurtz, J. E., Collard, O., Bertucci, F., Bompas, E., Le Cesne, A., Maki, R. G., Ray Coquard, I., Blay, J. Y.
Publicado em 2013

Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group

Por Ray-Coquard, I, Weber, B, Cretin, J, Haddad-Guichard, Z, Lévy, E, Hardy-Bessard, A C, Gouttebel, M C, Geay, J-F, Aleba, A, Orfeuvre, H, Agostini, C, Provencal, J, Ferrero, J M, Fric, D, Dohollou, N, Paraiso, D, Salvat, J, Pujade-Lauraine, É
Publicado em 2009

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial

Por Adenis, A., Blay, J.-Y., Bui-Nguyen, B., Bouché, O., Bertucci, F., Isambert, N., Bompas, E., Chaigneau, L., Domont, J., Ray-Coquard, I., Blésius, A., Van Tine, B. A., Bulusu, V. R., Dubreuil, P., Mansfield, C. D., Acin, Y., Moussy, A., Hermine, O., Le Cesne, A.
Publicado em 2014

Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group

Por Toulmonde, M., Bonvalot, S., Ray-Coquard, I., Stoeckle, E., Riou, O., Isambert, N., Bompas, E., Penel, N., Delcambre-Lair, C., Saada, E., Lecesne, A., Le Péchoux, C., Blay, J. Y., Piperno-Neumann, S., Chevreau, C., Bay, J. O., Brouste, V., Terrier, P., Ranchère-Vince, D., Neuville, A., Italiano, A.
Publicado no Ann Oncol (2014)